EX-FILING FEES 4 e6227_ex107.htm EXHIBIT 107

 

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

FORM S-1

(Form Type)

 

VIRPAX PHARMACEUTICALS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

Security Type   Security
Class Title		   Fee
Calculation
Rule		   Amount
to be
Registered		     Proposed
Maximum
Offering
Price Per
Unit		     Proposed
Maximum
Aggregate
Offering
Price(1)(2)		     Fee
Rate		     Amount of
Registration
Fee(3)		     Carry
Forward
Form
Type		     Carry
Forward
File
Number		     Carry
Forward
Initial
effective
date		     Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward		  
Equity   Common Stock, par value $0.00001 per share   Rule 457(o)     —       —     $ 6,000,000     $ 0.00015310     $ 918.6                                  
Equity   Pre-Funded Warrants to purchase Common Stock   Rule 457(o)     —       —       —     $ —     $ —                                  
Equity   Common Stock issuable upon exercise of the Pre-Funded Warrants(3)   Rule 457(i)     —       —       —       —       —                                  
Total Offering Amounts             $ 6,000,000             $ 918.6                                  
Total Fees Previously Paid                               —                                  
Total Fee Offsets                               —                                  
Net Fee Due                             $ 918.6                                  

 

  (1) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).

 

  (2) Pursuant to Rule 416(a) under the Securities Act, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.

 

  (3) The proposed maximum aggregate offering price of the Common Stock proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the aggregate offering price of the Pre-Funded Warrants offered and sold in the offering (plus the aggregate exercise price of the Common Stock issuable upon exercise of the Pre-Funded Warrants).